Verrica Pharmaceuticals Inc (VRCA) earnings · rev $35.6M
These earnings events as JSON? API free 100/dayVerrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
This VRCA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported VRCA revenue for 2025-12-31 was $35.6M. Net income was -$17.9M. Revenue was up 370.2% from 2024-12-31 to 2025-12-31. VRCA currently screens at market cap $79.7M.
When the next VRCA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 370.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full VRCA research stays on the stock page; the tape stays on the quote page.
VRCA earnings FAQ
What are VRCA's latest revenue and net income?
Latest cached Verrica Pharmaceuticals Inc (VRCA) revenue for Dec 31, 2025 was $35.6M. Net income was -$17.9M. Statements: https://lician.com/financials/vrca
What is VRCA's latest diluted EPS?
Latest cached Verrica Pharmaceuticals Inc (VRCA) diluted EPS for Dec 31, 2025 was -$1.68.
What period does the latest VRCA earnings print cover?
The latest cached Verrica Pharmaceuticals Inc (VRCA) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did VRCA revenue change from the prior cached period?
Cached Verrica Pharmaceuticals Inc (VRCA) revenue was up 370.2% from $7.6M (Dec 31, 2024) to $35.6M (Dec 31, 2025). Statements: https://lician.com/financials/vrca
Where are VRCA earnings listed?
Cached earnings facts for Verrica Pharmaceuticals Inc (VRCA) are listed at https://lician.com/earnings/vrca. Statements: https://lician.com/financials/vrca
Not investment advice.